Algernon to Become the First Company in the World to Study DMT for Stroke Patients
Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.
Day: May 18, 2021
What Is Psilohuasca? How and Why This Psychedelic Combo Is Going Mainstream
What is psilohuasca? This psychedelic combo marries MAO inhibitors with psilocin for an extended journey into healing.
End of content
End of content